Prospective, Open-label Trial to Evaluate Efficacy of Lyophilized Fecal Microbiota Transplantation for Treatment of Recurrent C. difficile Infection

BACKGROUND: Fecal microbiota transplantation (FMT) has shown to be effective for recurrent Clostridium difficile infection (rCDI). However, significant laboratory costs for donor screening and a lack of suitable donors and laboratory facility have restricted the availability of the treatment. In ord...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldeh, Peyman, Kim, Peter, Abouanaser, Salaheddin, Partlow, Eric, Beckett, Patricia, Onishi, Catherine, Smieja, Marek, Lee, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631555/
http://dx.doi.org/10.1093/ofid/ofx163.950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631555/
http://dx.doi.org/10.1093/ofid/ofx163.950

Ejemplares similares